Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

765 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04).
Salani R, McCormack M, Kim YM, Ghamande S, Hall SL, Lorusso D, Barraclough L, Gilbert L, Guzman Ramirez A, Lu CH, Sabatier R, Colombo N, Hu Y, Krishnan V, Molinero L, Feng Y, Kim N, Castro M, Lin YG, Monk BJ. Salani R, et al. Among authors: mccormack m. Int J Gynecol Cancer. 2024 Aug 5;34(8):1140-1148. doi: 10.1136/ijgc-2024-005588. Int J Gynecol Cancer. 2024. PMID: 38858106 Clinical Trial.
Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice.
Lorusso D, Colombo N, Herraez AC, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay SE, Ray-Coquard IL, Shapira-Frommer R, Kim YM, McCormack M, Massaad R, Nguyen AM, Zhao Q, McKenzie J, Prabhu VS, Makker V. Lorusso D, et al. Among authors: mccormack m. Eur J Cancer. 2023 Jun;186:172-184. doi: 10.1016/j.ejca.2023.03.015. Epub 2023 Mar 23. Eur J Cancer. 2023. PMID: 37086595 Free PMC article. Clinical Trial.
Highlights from the 25th European Congress on Gynaecological Oncology in Barcelona: the ENYGO-IJGC Fellow Interviews.
Angeles MA, Agusti N, Bonaldo G, Bizzarri N, Bilir E, Piedimonte S, Olearo E, Navarro Santana B, Sahin Aker S, El Hajj H, Ghirardi V, Kacperczyk-Bartnik J, Strojna AN, Fotopoulou C, Plante M, Lorusso D, Cibula D, Lindemann K, Scambia G, McCormack M, Leitao M, Fagotti A, Concin N, Martinez A, Ramirez PT. Angeles MA, et al. Among authors: mccormack m. Int J Gynecol Cancer. 2024 Oct 7;34(10):1522-1528. doi: 10.1136/ijgc-2024-005704. Int J Gynecol Cancer. 2024. PMID: 39181697
A multicenter retrospective study to assess feasibility, safety and efficacy of first-line carboplatin-paclitaxel versus carboplatin monotherapy in a frail, elderly epithelial ovarian cancer population.
Merry E, Kesmez RT, Yu T, Flynn M, Ledermann J, Lockley M, Macdonald N, McCormack M, Nicum S, Crusz S, Miller R. Merry E, et al. Among authors: mccormack m. Int J Gynecol Cancer. 2024 Sep 3:ijgc-2024-005394. doi: 10.1136/ijgc-2024-005394. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 39231541
INTERLACE in practice.
Eminowicz G, Diez P, McCormack M. Eminowicz G, et al. Among authors: mccormack m. Int J Gynecol Cancer. 2025 Jan 6:ijgc-2024-006098. doi: 10.1136/ijgc-2024-006098. Online ahead of print. Int J Gynecol Cancer. 2025. PMID: 39461742 No abstract available.
The implications of removing race from interpretation of pulmonary function among persons with or without HIV.
Wang RJ, Kunisaki KM, Morris A, Drummond MB, Nouraie M, Huang L, Tien PC, Baugh AD, Barjaktarevic I, Bhandari N, Bhatt SP, D'Souza G, Fischl MA, Foronjy RF, Jensen RL, Lazarous DG, Ofotokun I, Reddy D, Stosor V, McCormack MC, Raju S. Wang RJ, et al. Among authors: mccormack mc. J Acquir Immune Defic Syndr. 2024 Dec 3. doi: 10.1097/QAI.0000000000003579. Online ahead of print. J Acquir Immune Defic Syndr. 2024. PMID: 39623526
765 results